37
Cervical cancer risk following three rounds of human papillomavirus (HPV) and cytology co-testing in a one million-women cohort
Sunday, March 29, 2015: 5:47 PM
International Ballroom (Hilton Chicago)
P. E. Castle1,2, F. H. Zhao3, W. K. Kinney4, L. Cheung5, M. Schiffman6, B. Fetterman7, N. Poitras7, T. Lorey7, J. Gage6, N. Wentzensen6 and H. Katki6
1Global Coalition Against Cervical Cancer, Arlington, VA, 2Albert Einstein College of Medicine, New York, NY, 3Cancer Institute Chinese Academy of Medical Sciences, Beijing, China, 4The Permanente Medical Group, Sacramento, CA, 5Information Management Services, Calverton, MD, 6National Cancer Institute, Bethesda, MD, 7The Permanente Medical Group, Berkeley, CA
